Literature DB >> 6259297

Cytomegalovirus labyrinthitis in an infant: morphological, virological, and immunofluorescent studies.

L E Davis, L G Johnsson, M Kornfeld.   

Abstract

The inner ears obtained from an infant who died of severe congenital cytomegalovirus infection were examined using virological and morphological methods. The techniques of microdissection and surface preparations, immunofluorescent microscopy, and transmission and scanning electron microscopy were employed. Cytomegalovirus was isolated from the perilymph. Injury to the cochlea was minor and was confined to the first half of the basal turn. There were signs of a severe labyrinthitis of the vestibular endolymphatic system. Vestibular organs, especially the saccule and utricle, showed severe damage, with collapse of the saccular membranous wall. Inclusion-bearing cells containing cytomegalovirus antigen, as shown by immunofluorescent staining, and cytomegalovirus virions, as observed by electron microscopy, were found on the endolymphatic surface of the membranous walls, mainly in the saccule and utricle. In the utricle, the infected cells appeared to be concentrated in the regions where the so-called dark cells were located. These dark cells are similar to the proximal tubule cells in the kidney, another common target for cytomegalovirus infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259297

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  12 in total

1.  Congenital cytomegalovirus infection: a cause of sensorineural hearing loss.

Authors:  C S Peckham; O Stark; J A Dudgeon; J A Martin; G Hawkins
Journal:  Arch Dis Child       Date:  1987-12       Impact factor: 3.791

2.  Labyrinthitis Ossificans in a Cynomolgus Macaque (Macaca fascicularis).

Authors:  Gayathriy Balamayooran; Hannah M Atkins; Christopher T Whitlow; Samuel T Aycock; Michael A Nader; J Mark Cline; David L Caudell
Journal:  Comp Med       Date:  2018-04-12       Impact factor: 0.982

Review 3.  The use of antiviral drugs during the neonatal period.

Authors:  Richard J Whitley
Journal:  Clin Perinatol       Date:  2012-01-21       Impact factor: 3.430

4.  Impact of a cytomegalovirus kinase inhibitor on infection and neuronal progenitor cell differentiation.

Authors:  Tarin M Bigley; Jered V McGivern; Allison D Ebert; Scott S Terhune
Journal:  Antiviral Res       Date:  2016-02-11       Impact factor: 5.970

5.  Cytomegalovirus-induced pathology in human temporal bones with congenital and acquired infection.

Authors:  Vladimir Tsuprun; Nevra Keskin; Mark R Schleiss; Pat Schachern; Sebahattin Cureoglu
Journal:  Am J Otolaryngol       Date:  2019-08-02       Impact factor: 1.808

6.  Human cytomegalovirus downregulates SLITRK6 expression through IE2.

Authors:  Huanan Liao; Haruna Sato; Ryosuke Chiba; Tomoko Kawai; Kazuhiko Nakabayashi; Kenichiro Hata; Hidenori Akutsu; Shigeyoshi Fujiwara; Hiroyuki Nakamura
Journal:  J Neurovirol       Date:  2016-08-16       Impact factor: 2.643

7.  Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis.

Authors:  N K Woolf; J W Ochi; E J Silva; P A Sharp; J P Harris; D D Richman
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

8.  Murine model for congenital CMV infection and hearing impairment.

Authors:  Chen Juanjuan; Feng Yan; Chen Li; Liu Haizhi; Wang Ling; Wang Xinrong; Xiao Juan; Liu Tao; Yin Zongzhi; Chen Suhua
Journal:  Virol J       Date:  2011-02-15       Impact factor: 4.099

Review 9.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 10.  Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.

Authors:  Scott H James; David W Kimberlin; Richard J Whitley
Journal:  Antiviral Res       Date:  2009-05-04       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.